1. Home
  2. CULP vs SNTI Comparison

CULP vs SNTI Comparison

Compare CULP & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$3.47

Market Cap

52.7M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.19

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
SNTI
Founded
1972
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.7M
53.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CULP
SNTI
Price
$3.47
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.00
AVG Volume (30 Days)
42.8K
4.4M
Earning Date
12-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$204,919,000.00
N/A
Revenue This Year
$1.93
N/A
Revenue Next Year
$2.77
$150.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.42
$1.15
52 Week High
$5.94
$5.10

Technical Indicators

Market Signals
Indicator
CULP
SNTI
Relative Strength Index (RSI) 29.69 33.70
Support Level $3.42 $1.15
Resistance Level $3.82 $1.29
Average True Range (ATR) 0.14 0.23
MACD -0.04 -0.08
Stochastic Oscillator 1.61 2.19

Price Performance

Historical Comparison
CULP
SNTI

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: